Total Utang marang Modal NeuroMetrix (NURO)

NeuroMetrix, Inc. (NURO) - logo korporat

NeuroMetrix, Inc. (NURO) is expanding the availability of Quell pain management systems through pharmacies and digital monitoring. This chart on GURU.Markets for the separate_debt_total_eq metric shows 0.01, while weak pricing power due to limited insurance coverage makes demand sensitive. The company generates revenue from the sale of neurostimulators and diagnostic equipment for clinics and individuals with neuropathy.

NURO: Rasio Utang marang Ekuitas neurometrix.com 04.07.2022 - 11.05.2025

Rincian analitis perusahaan NeuroMetrix, Inc.

- rega lan prakiraan konsensus rega:
Bagan rega NeuroMetrix|NURO - Target konsensus
- rincian kapitalisasi pasar:
Kapitalisasi pasar NeuroMetrix|NURO - Total Nilai Perusahaan
- indikator kapitalisasi buku:
Nilai Buku saben Saham NeuroMetrix|NURO - Kapitalisasi Akuntansi|Rasio Kapitalisasi Pasar marang Nilai Buku neurometrix.com|NURO - Gunggung Aset Perusahaan
- indikator beban kredit lan likuiditas emiten:
Total Utang marang Modal NeuroMetrix, Inc.|NURO - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal NeuroMetrix, Inc.|NURO - Gunggung utang perusahaan|Rasio utang marang kapitalisasi buku NeuroMetrix|NURO - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan NeuroMetrix|Rasio cepet neurometrix.com
- informasi bathi lan kelipatan valuasi:
NURO - Asil keuangan resik
Analisis dhasar perusahaan:NURO, NeuroMetrix
Produk dadi NeuroMetrix Corporation

The Debt-to-Equity ratio measures the proportion of borrowed funds relative to shareholders' equity, allowing investors to assess financial leverage and the balance sheet's resilience to changes in Fed rates. Analyzing the balance between debt and equity helps filter out market noise to determine whether NeuroMetrix, Inc. (NURO) possesses sufficient resources to scale Quell device sales through pharmacy chains and implement digital monitoring platforms.

Pesaing wigati

Utang marang Ekuitas Intuitive|Rasio Total Utang marang Ekuitas Danaher Corporation (DHR)|Total Utang marang Modal BDX|STE - Utang marang Modal|Total Utang marang Modal WST (West Pharmaceutical Services)|BAX: Rasio Utang marang Ekuitas|Masimo - Total Utang marang Modal|Koefisien Total Utang marang Modal Stevanato Group SpA STVN|TFX: Total Utang marang Modal|Rasio Total Utang marang Ekuitas Merit Medical Corp|NVST (Envista Holdings) - Total Utang marang Modal|Total Utang marang Modal icumed.com|Utang marang Ekuitas Dentsply Sirona (XRAY)|Utang marang Ekuitas LMAT (LeMaitre Vascular Inc)|AtriCure Corp - Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi STAA|ChromaDex Corp. - Total Utang marang Modal|Koefisien Total Utang marang Modal zimvie.com ZIMV|AngioDynamics (ANGO) - Utang marang Ekuitas|Rasio Utang marang Ekuitas CERS|Utang marang Ekuitas Alpha Teknova Inc|Monogram Orthopedics Inc. (MGRM) - Koefisien Total Utang marang Modal|Rasio Total Utang marang Ekuitas STSS (Sharps Technology, Inc.)|Utang Agregat marang Modal INFU|Utang marang Ekuitas Utah Medical Products, Inc. UTMD|Rasio Kabeh Utang marang Dana Pribadi KRMD|NYXH: Rasio Total Utang marang Ekuitas|MBOT - Total Utang marang Modal|Pro-Dex, Inc. (PDEX) - Utang marang Ekuitas|Rasio Total Utang marang Ekuitas zentek.com|ELUT (Elutia) - Total Utang marang Modal|Utang marang Modal Milestone Scientific Inc MLSS|Utang marang Ekuitas NEXGEL, Inc (NXGL)|retractable.com - Rasio Utang marang Ekuitas|Harvard Bioscience, Inc. - Rasio Total Utang marang Ekuitas|Utang Agregat marang Modal FEMY (femasys.com)|MHUA - Utang marang Ekuitas|Koefisien Total Utang marang Modal Predictive Oncology POAI|callanjmb.com (CJMB) - Utang marang Ekuitas|Rasio Utang marang Ekuitas ATRI